Mark J. Kiel
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 0.5%
- Mesenchymal stem cell research
Papers in
- Hematology 13
- Hematopoietic Stem Cell Transplantation 12
- Acute Myeloid Leukemia Research 3
-
- Cutaneous lymphoproliferative disorders research 5
- Co-authors
- Sean J. MorrisonÖmer YılmazToshihide IwashitaOsman YılmazCox TerhorstDalong QianIrving L. WeissmanMichael F. Clarke
- Journals
- Blood (8 papers)Orphanet Journal of Rare Diseases (2 papers)Nature (2 papers)Human Mutation (2 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Mark J. Kiel
37 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 3.1k
- Genetics 1.5k
- Immunology 2.0k
- Oncology 1.7k
- Cancer Research 646
Countries citing papers authored by Mark J. Kiel
This map shows the geographic impact of Mark J. Kiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Kiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Kiel more than expected).
Fields of papers citing papers by Mark J. Kiel
This network shows the impact of papers produced by Mark J. Kiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Kiel. The network helps show where Mark J. Kiel may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Kiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 11 | |
| 5 | 2021 | 27 | |
| 6 | 2019 | 9 | |
| 7 | 2015 | 143 | |
| 8 | 2015 | 109 | |
| 9 | 2014 | 234 | |
| 10 | 2010 | 46 | |
| 11 | 2009 | 130 | |
| 12 | 2008 | 421 | |
| 13 | 2007 | 251 | |
| 14 | 2006 | 104 | |
| 15 | 2005 | 44 | |
| 16 | 2005 | 25 | |
| 17 | SLAM Family Receptors Distinguish Hematopoietic Stem and Progenitor Cells and Reveal Endothelial Niches for Stem Cells Hit paper breakdown → | 2005 | 2366 |
| 18 | 2005 | 196 | |
| 19 | Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells Hit paper breakdown → | 2003 | 1456 |
| 20 | 2002 | 80 |
About Mark J. Kiel
Mark J. Kiel is a scholar working on Hematology, Dermatology, Immunology, Pathology and Forensic Medicine and Genetics, having authored 37 papers that have together received 7.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (5 papers), T-cell and B-cell Immunology (4 papers), Zebrafish Biomedical Research Applications (3 papers), Cancer Genomics and Diagnostics (3 papers), Acute Myeloid Leukemia Research (3 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (1.5k citations), Immunology (2.0k citations), Oncology (1.7k citations) and Cancer Research (646 citations). Mark J. Kiel has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Sean J. Morrison, Ömer Yılmaz, Toshihide Iwashita, Osman Yılmaz, Cox Terhorst, Dalong Qian, Irving L. Weissman, Michael F. Clarke, In-Kyung Park and Michael W. Becker. Their work appears in journals such as Blood, Orphanet Journal of Rare Diseases, Nature, Human Mutation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.